ENDORFICA

Alkermes Pharma Ireland Limited

Application Filed: 2017-06-13

Trademark Application Details

Status

733

Live/Pending

FOURTH EXTENSION - GRANTED

Research	OneLook Acronym Finder
Serial Number	87486031
Mark Drawing Code	4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form
Attorney Name	Norm J. Rich
Attorney Docket Number	029318-2743
Law Office Assigned	N70
Employee Name	INGRAM, KYLE G

Timeline

2017-06-13	Application Filed
2017-08-29	Published for Opposition
2017-10-24	Location: INTENT TO USE SECTION
2019-10-11	Status: Live/Pending
2019-10-15	Transaction Date

Trademark Applicants & Owners

Owner:	Alkermes Pharma Ireland Limited
Address	CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN IE
Legal Entity Type	Corporation
Legal Entity State	IE

Documents

Click the blue "Refresh" button to load certificates, specimines, application, and other documents.

Attorney of Record

NORM J. RICH
FOLEY & LARDNER LLP
SIXTH FLOOR
3000 K STREET, N.W.
WASHINGTON DC 20007

Good, Services, and Codes

International Codes:	5
U.S. Codes:	006,018,044,046,051,052

Type Code	Type
GS0051	Pharmaceutical preparations for the treatment of diseases mediated by an opioid receptor, namely, major depressive disorder, chronic depression, severe unipolar recurrent major depressive episodes, dysthymic disorder, depressive neurosis and neurotic depression, melancholic depression, atypical depression, reactive depression, treatment resistant depression, seasonal affective disorder and pediatric depression, premenstrual syndrome, premenstrual dysphoric disorder, hot flashes, bipolar disorders or manic depression, bipolar I disorder, bipolar II disorder and cyclothymic disorder, anxiety, post traumatic stress disorder, obsessive compulsive disorder and borderline personality disorder

Type Code

Type

GS0051

Pharmaceutical preparations for the treatment of diseases mediated by an opioid receptor, namely, major depressive disorder, chronic depression, severe unipolar recurrent major depressive episodes, dysthymic disorder, depressive neurosis and neurotic depression, melancholic depression, atypical depression, reactive depression, treatment resistant depression, seasonal affective disorder and pediatric depression, premenstrual syndrome, premenstrual dysphoric disorder, hot flashes, bipolar disorders or manic depression, bipolar I disorder, bipolar II disorder and cyclothymic disorder, anxiety, post traumatic stress disorder, obsessive compulsive disorder and borderline personality disorder

Trademark Filing History

Description	Date	Event Coding
NEW APPLICATION ENTERED IN TRAM	2017-06-16	1 NWAP I:Incoming Correspondence
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM	2017-06-19	2 NWOS I:Incoming Correspondence
ASSIGNED TO EXAMINER	2017-07-21	3 DOCK D:Assigned to Examiner
APPROVED FOR PUB - PRINCIPAL REGISTER	2017-07-21	4 CNSA P:
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED	2017-08-09	5 NONP E:E-Mail
PUBLISHED FOR OPPOSITION	2017-08-29	6 PUBO A:Allowance for Publication
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED	2017-08-29	7 NPUB E:E-Mail
NOA E-MAILED - SOU REQUIRED FROM APPLICANT	2017-10-24	8 NOAM E:E-Mail
TEAS EXTENSION RECEIVED	2018-01-29	9 EEXT I:Incoming Correspondence
EXTENSION 1 FILED	2018-01-29	10 EXT1 S:
EXTENSION 1 GRANTED	2018-01-29	11 EX1G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	2018-01-31	12 EXRA E:E-Mail
TEAS EXTENSION RECEIVED	2018-09-10	13 EEXT I:Incoming Correspondence
EXTENSION 2 FILED	2018-09-10	14 EXT2 S:
EXTENSION 2 GRANTED	2018-09-10	15 EX2G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	2018-09-12	16 EXRA E:E-Mail
TEAS EXTENSION RECEIVED	2019-02-27	17 EEXT I:Incoming Correspondence
EXTENSION 3 FILED	2019-02-27	18 EXT3 S:
EXTENSION 3 GRANTED	2019-02-27	19 EX3G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	2019-03-01	20 EXRA E:E-Mail
TEAS EXTENSION RECEIVED	2019-10-11	21 EEXT I:Incoming Correspondence
EXTENSION 4 FILED	2019-10-11	22 EXT4 S:
EXTENSION 4 GRANTED	2019-10-11	23 EX4G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	2019-10-15	24 EXRA E:E-Mail
TEAS EXTENSION RECEIVED	2020-04-17	25 EEXT I:Incoming Correspondence
CASE ASSIGNED TO INTENT TO USE PARALEGAL	2020-04-25	26 AITU A:Allowance for Publication
EXTENSION 5 FILED	2020-04-17	27 EXT5 S:
EXTENSION 5 GRANTED	2020-04-25	28 EX5G S:
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	2020-04-28	29 EXRA E:E-Mail
ABANDONMENT - NO USE STATEMENT FILED	2020-11-30	30 ABN6 S:
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED	2020-11-30	31 MAB6 E:E-Mail

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.